Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Human Growth Hormone Companies

There are several pharmaceutical companies that produce and market growth hormone products. Growth hormone is a peptide hormone essential for the growth and development of tissues and organs in the human body. It is also known as somatotropin and is produced by the pituitary gland. When there is a deficiency of growth hormone in the body, it can lead to growth disorders and other medical conditions

*Disclaimer: List of key companies in no particular orderLatest Growth hormone Companies Update

June 2023: Pfizer Inc. and its partner, OPKO Health Inc., announced that the U.S. Food and Drug Administration (FDA) had authorized their medication for childhood growth hormone insufficiency. Pfizer's stock rose by less than 1 percent in premarket trade, while Opko Health's rose by more than 27 percent, after the FDA approved the medicine. Hormone therapy authorized for use in children as young as three years old and to be marketed under the brand name Ngenla. In August, it will hit shelves in the United States.

August 2023: Genexine, a publicly traded Korean biopharmaceutical company, released favorable top-line findings from a pivotal phase 3 study conducted in China. This study aims to assess the effectiveness and safety of eftansomatropin alfa, also known as GX-H9, Genexine's proprietary long-acting growth hormone, in children diagnosed with growth hormone deficiency. The once-weekly growth hormone developed by Genexine, in collaboration with I-Mab and Jumpcan, has demonstrated comparable efficacy to daily injections in a significant experiment conducted in China. These promising results position the companies to pursue regulatory clearance in the next year and make preparations for the subsequent sale of this medication.

September 2023: Ascendis Pharma A/S disclosed the findings of enliGHten, an open-label extension experiment conducted by the company. The trial aimed to assess the prolonged safety and effectiveness of TransCon hGH, administered once a week, as a therapeutic option for children and adolescents diagnosed with growth hormone deficiency (GHD). The enliGHten trial had a total of 298 individuals, with a mean age of 10.3 years. The participants enrolled in these clinical studies were administered a cumulative treatment duration of up to six years with TransCon hGH.

List of Growth hormone Key companies in the market

Novo Nordisk A/S (Denmark)

Pfizer Inc. (US)

Ascendis Pharma A/S (Denmark)

EMD Serono (US)

Ferring B.V. (Switzerland‎)

Zhongshan Sinobioway Hygene Biomedicine Co., Ltd (China)

Sandoz International GmbH (Germany)

AnkeBio Co., Ltd (China)

Ipsen Pharma (France)

Genentech (US)

Human Growth Hormone Market Highlights:

Human Growth Hormone Market Size

Human Growth Hormone Market Trends

Human Growth Hormone Market Analysis

Human Growth Hormone Market Share

Human Growth Hormone Market Highlights:

Human Growth Hormone Market Trends

Human Growth Hormone Market Analysis

Human Growth Hormone Market Share

Human Growth Hormone Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.